Dexmethylphenidate
Back to searchMolecule Structure
Scientific Name
Dexmethylphenidate
Description of the Drug
Dexmethylphenidate is a norepinephrine-dopamine reuptake inhibitor used in the treatment of ADHD in conjunction with other therapies.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06701
http://www.drugbank.ca/drugs/DB06701
Brand Name(s)
Not Available
Company Owner(s)
Alkem Laboratories Ltd, Abhai Inc, Sun Pharmaceutical Industries Inc, Rhodes Pharmaceuticals Lp, Granules Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Impax Laboratories Inc, Bionpharma Inc, Aurolife Pharma Llc, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL238 |
| Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34326 | ||
| Human Metabolome Database | HMDB0015647 | ||
| DrugBank | DB06701 | ||
| PubChem: Thomson Pharma | 15121721 | 14847270 | |
| PubChem | 154101 | ||
| Nikkaji | J343.157F | ||
| BindingDB | 50062915 | ||
| EPA CompTox Dashboard | DTXSID70893769 | ||
| DrugCentral | 836 | ||
| Brenda | 72091 | 161119 | |
| Guide to Pharmacology | 7554 | ||
| rxnorm | DEXMETHYLPHENIDATE HYDROCHLORIDE | DEXMETHYLPHENIDATE | FOCALIN |
| ChEBI | 51860 | ||
| ZINC | ZINC000000896711 |
